What Tecnis Eyhance is
Tecnis Eyhance is marketed by its manufacturer as the first "enhanced monofocal" IOL — a category positioned between standard monofocal lenses and full presbyopia-correcting multifocal or trifocal lenses. It has been available since 2019, so there is now a reasonably substantial base of clinical use and real-world experience behind it, in addition to the manufacturer's own published data.
The optic uses aspheric technology with a proprietary refractive design on the posterior surface, rather than the diffractive rings used in multifocal lenses. It's made from hydrophobic acrylic, is available across an optical power range of roughly +5.0D to +34.0D, and comes in toric versions for patients who also need astigmatism correction.
What it looks like
Eyhance's optic uses a proprietary design. We checked the FDA's public filings, the manufacturer's newsroom and press pages, distributor listings, and the open peer-reviewed literature, and found no independently published photograph or render of the lens that's actually available to the public — the only real product photography we could find lives behind the manufacturer's professional-only portal, restricted to healthcare providers, which by definition means it was never made available to the public. Rather than substitute a stock photo of a different lens or a drawing that might not resemble the real thing, we're leaving this section as text until a legitimate public source exists.
What the design aims to do
Unlike a diffractive multifocal, which splits light between two or three focal points, Eyhance uses a continuous refractive change in curvature to stretch a single focal point into a slightly extended range. The manufacturer describes this as improving visual acuity across roughly -0.5D to -1.5D of defocus compared with a standard monofocal, with visual acuity at about 66 cm (roughly arm's length) reported around 0.2 logMAR — a level generally considered sufficient for routine intermediate tasks like reading a car dashboard or using a laptop, though not equivalent to reading small print.
The manufacturer's published defocus-curve data reportedly shows a meaningful improvement in intermediate visual acuity compared with a standard monofocal lens, and this general pattern is broadly consistent with independent clinical experience and patient feedback reported since launch. As with any manufacturer-published defocus curve, it's worth treating the exact figures as reported data rather than an independently verified guarantee for any individual eye.
Realistic vision expectations by distance
- Distance vision. Generally very good. Most patients who achieve a well-targeted, close-to-plano refraction reach around 20/20 distance acuity. Some report subjective sharpness marginally below a basic monofocal, though in practice the two are close.
- Intermediate vision. This is the lens's central selling point. Reported visual acuity at arm's length is generally better than with a standard monofocal, which can reduce — though not necessarily eliminate — the need for glasses during everyday intermediate tasks such as computer work, cooking, or dashboard viewing.
- Near vision. Reading glasses are still generally needed for sustained close work like small print, though near vision tends to be modestly better than with a basic monofocal lens.
- Day versus night vision. The optical design is non-diffractive, and the visual experience is generally reported as similar in daylight and after dark, without a distinct night-specific trade-off built into the design.
- Contrast sensitivity. Reported as comparable to a standard high-quality monofocal lens (the manufacturer cites its own Tecnis-1 monofocal, a lens with a strong contrast-sensitivity track record, as the benchmark). This matters because it suggests Eyhance is not expected to meaningfully trade away contrast in order to gain its added intermediate range — one of the more consistent appeals of this lens relative to more aggressive presbyopia-correcting designs.
- Halos and glare. Not typically associated with this lens. Because it is a non-diffractive, refractive design rather than a diffractive multifocal, night vision is generally reported as clear, without the halo rings around lights that some patients notice with trifocal or multifocal IOLs.
Who this lens may suit
Eyhance tends to come up for patients who:
- Want a comfortable, predictable outcome for daily activities and are willing to wear reading glasses for close work.
- Would like somewhat better spectacle independence at intermediate distances than a standard monofocal offers, without moving to a full presbyopia-correcting multifocal or trifocal lens.
- Have clinical factors — mild macular changes, glaucoma, an irregular cornea, or similar — that make more aggressive multifocal or trifocal designs a poorer fit, but who find a fully basic monofocal unnecessarily limiting given otherwise healthy eyes.
Whether any of this applies to your own eyes is a question for your surgeon, based on your measurements, ocular health, and visual priorities — not something to decide from a general article like this one.
How it compares
Eyhance sits within the broader enhanced monofocal category, alongside other lenses built around the same basic idea of stretching a single focal point rather than splitting light diffractively. For a side-by-side look at the category as a whole — including trade-offs relative to standard monofocal and full-range lenses — see Enhanced Monofocal IOLs.
If you'd like to compare Eyhance against other specific enhanced monofocal models, Enhanced monofocal IOLs: the current landscape looks at how several lenses in this category differ from one another.
A note on this review
This page is educational content, not a clinical trial result and not a personal recommendation. It summarizes manufacturer-reported design data alongside general patterns from published and real-world experience. Actual outcomes vary from patient to patient, and the right lens for you can only be determined by a qualified ophthalmic surgeon based on your individual eye measurements and health history.